APO Research
Talk to an analyst

APO RESEARCH · REPORT

Human Hepatitis B Immunoglobulin (HBIG)

Compare research editions
View pricing & licenses

Selected research

Market Analysis & Forecast

Global Human Hepatitis B Immunoglobulin (HBIG) Market Analysis and Forecast 2026-2032

26 December 2025190 pages

Choose your research edition.

Industry ResearchHuman Hepatitis B Immunoglobulin (HBIG) Industry Research Report 2026127 pages · $2,950 USDIndustry Growth & TrendsGlobal Human Hepatitis B Immunoglobulin (HBIG) Industry Growth and Trends Forecast to 2032102 pages · $3,450 USDMarket StructureGlobal Human Hepatitis B Immunoglobulin (HBIG) Market by Size, by Type, by Application, by Region, History and Forecast 2021-2032197 pages · $3,950 USDMarket Outlook & Growth OpportunitiesGlobal Human Hepatitis B Immunoglobulin (HBIG) Market Outlook and Growth Opportunities 2026192 pages · $4,250 USDMarket Analysis & ForecastGlobal Human Hepatitis B Immunoglobulin (HBIG) Market Analysis and Forecast 2026-2032190 pages · $4,950 USD

Market perspective

The global Human Hepatitis B Immunoglobulin (HBIG) market is projected to grow from US$ million in 2026 to US$ million by 2032, at a Compound Annual Growth Rate (CAGR) of % during the forecast period.

The US & Canada market for Human Hepatitis B Immunoglobulin (HBIG) is estimated to increase from $ million in 2026 to reach $ million by 2032, at a CAGR of % during the forecast period of 2026 through 2032.

Europe market for Human Hepatitis B Immunoglobulin (HBIG) is estimated to increase from $ million in 2026 to reach $ million by 2032, at a CAGR of % during the forecast period of 2026 through 2032.

Read the full market overview

Asia-Pacific market for Human Hepatitis B Immunoglobulin (HBIG) is estimated to increase from $ million in 2026 to reach $ million by 2032, at a CAGR of % during the forecast period of 2026 through 2032.

The China market for Human Hepatitis B Immunoglobulin (HBIG) is estimated to increase from $ million in 2026 to reach $ million by 2032, at a CAGR of % during the forecast period of 2026 through 2032.

The major global manufacturers of Human Hepatitis B Immunoglobulin (HBIG) include Boya Bio-pharmaceutical, CSL, Grifols, Octapharma, Baxter, Bayer, Tiantan Biologic, Shuanglin Bio-pharmacy and Hualan Biological, etc. In 2025, the world's top three vendors accounted for approximately % of the revenue.

This report presents an overview of global market for Human Hepatitis B Immunoglobulin (HBIG), sales, revenue and price. Analyses of the global market trends, with historic market revenue or sales data for 2021 - 2025, estimates for 2026, and projections of CAGR through 2032.

This report researches the key producers of Human Hepatitis B Immunoglobulin (HBIG), also provides the sales of main regions and countries. Of the upcoming market potential for Human Hepatitis B Immunoglobulin (HBIG), and key regions or countries of focus to forecast this market into various segments and sub-segments. Country specific data and market value analysis for the U.S., Canada, Mexico, Brazil, China, Japan, South Korea, Southeast Asia, India, Germany, the U.K., Italy, Middle East, Africa, and Other Countries.

This report focuses on the Human Hepatitis B Immunoglobulin (HBIG) sales, revenue, market share and industry ranking of main manufacturers, data from 2021 to 2026. Identification of the major stakeholders in the global Human Hepatitis B Immunoglobulin (HBIG) market, and analysis of their competitive landscape and market positioning based on recent developments and segmental revenues. This report will help stakeholders to understand the competitive landscape and gain more insights and position their businesses and market strategies in a better way.

This report analyzes the segments data by Type and by Application, sales, revenue, and price, from 2021 to 2032. Evaluation and forecast the market size for Human Hepatitis B Immunoglobulin (HBIG) sales, projected growth trends, production technology, application and end-user industry.

Human Hepatitis B Immunoglobulin (HBIG) Segment by Company

Boya Bio-pharmaceutical

CSL

Grifols

Octapharma

Baxter

Bayer

Tiantan Biologic

Shuanglin Bio-pharmacy

Hualan Biological

Shanghai RAAS

Sichuan Yuanda Shuyang

China Biologic

Shanghai Institute of Biological

Human Hepatitis B Immunoglobulin (HBIG) Segment by Type

100IU/Bottle Human Hepatitis B Immunoglobulin

200IU/Bottle Human Hepatitis B Immunoglobulin

400IU/Bottle Human Hepatitis B Immunoglobulin

Human Hepatitis B Immunoglobulin (HBIG) Segment by Application

Close Contacts of Patients with Hepatitis B and Hepatitis B Virus Carriers

Positive Infants Born to Mothers With Hepatitis B Surface Antigen(HBsAg)

Unexpected Crowd of Hepatitis B Infection

Human Hepatitis B Immunoglobulin (HBIG) Segment by Region

North America

United States

Canada

Mexico

Europe

Germany

France

U.K.

Italy

Russia

Spain

Netherlands

Switzerland

Sweden

Poland

Asia-Pacific

China

Japan

South Korea

India

Australia

Taiwan

Southeast Asia

South America

Brazil

Argentina

Chile

Middle East & Africa

Egypt

South Africa

Israel

Türkiye

GCC Countries

Study Objectives

1. To analyze and research the global status and future forecast, involving growth rate (CAGR), market share, historical and forecast.

2. To present the key manufacturers, sales, revenue, market share, and Recent Developments.

3. To split the breakdown data by regions, type, manufacturers, and Application.

4. To analyze the global and key regions market potential and advantage, opportunity and challenge, restraints, and risks.

5. To identify significant trends, drivers, influence factors in global and regions.

6. To analyze competitive developments such as expansions, agreements, new product launches, and acquisitions in the market.

Reasons to Buy This Report

1. This report will help the readers to understand the competition within the industries and strategies for the competitive environment to enhance the potential profit. The report also focuses on the competitive landscape of the global Human Hepatitis B Immunoglobulin (HBIG) market, and introduces in detail the market share, industry ranking, competitor ecosystem, market performance, new product development, operation situation, expansion, and acquisition. etc. of the main players, which helps the readers to identify the main competitors and deeply understand the competition pattern of the market.

2. This report will help stakeholders to understand the global industry status and trends of Human Hepatitis B Immunoglobulin (HBIG) and provides them with information on key market drivers, restraints, challenges, and opportunities.

3. This report will help stakeholders to understand competitors better and gain more insights to strengthen their position in their businesses. The competitive landscape section includes the market share and rank (in sales and value), competitor ecosystem, new product development, expansion, and acquisition.

4. This report stays updated with novel technology integration, features, and the latest developments in the market.

5. This report helps stakeholders to gain insights into which regions to target globally.

6. This report helps stakeholders to gain insights into the end-user perception concerning the adoption of Human Hepatitis B Immunoglobulin (HBIG).

7. This report helps stakeholders to identify some of the key players in the market and understand their valuable contribution.

Chapter Outline

Chapter 1: Introduces the report scope of the report, executive summary of different market segments (by type and by application, etc), including the market size of each market segment, future development potential, and so on. It offers a high-level view of the current state of the market and its likely evolution in the short to mid-term, and long term.

Chapter 2: Introduces the market dynamics, latest developments of the market, the driving factors and restrictive factors of the market, the challenges and risks faced by manufacturers in the industry, and the analysis of relevant policies in the industry.

Chapter 3: Sales (consumption), revenue of Human Hepatitis B Immunoglobulin (HBIG) in global, regional level and country level. It provides a quantitative analysis of the market size and development potential of each region and its main countries and introduces the market development, future development prospects, market space of each country in the world.

Chapter 4: Detailed analysis of Human Hepatitis B Immunoglobulin (HBIG) manufacturers competitive landscape, price, sales, revenue, market share and industry ranking, latest development plan, merger, and acquisition information, etc.

Chapter 5: Provides the analysis of various market segments by type, covering the sales, revenue, average price, and development potential of each market segment, to help readers find the blue ocean market in different market segments.

Chapter 6: Provides the analysis of various market segments by application, covering the sales, revenue, average price, and development potential of each market segment, to help readers find the blue ocean market in different downstream markets.

Chapter 7: Provides profiles of key manufacturers, introducing the basic situation of the main companies in the market in detail, including product descriptions and specifications, Human Hepatitis B Immunoglobulin (HBIG) sales, revenue, price, gross margin, and recent development, etc.

Chapter 8: North America by type, by application and by country, sales, and revenue for each segment.

Chapter 9: Europe by type, by application and by country, sales, and revenue for each segment.

Chapter 10: China type, by application, sales, and revenue for each segment.

Chapter 11: Asia (excluding China) type, by application and by region, sales, and revenue for each segment.

Chapter 12: South America, Middle East and Africa by type, by application and by country, sales, and revenue for each segment.

Chapter 13: Analysis of industrial chain, sales channel, key raw materials, distributors and customers.

Chapter 14: The main concluding insights of the report.

More report detail

Tables and figures
List of Tables Table 1. Global Human Hepatitis B Immunoglobulin (HBIG) Market Size Growth Rate by Type (US$ Million), 2021 VS 2025 VS 2032 Table 2. 100IU/Bottle Human Hepatitis B Immunoglobulin Major Manufacturers Table 3. 200IU/Bottle Human Hepatitis B Immunoglobulin Major Manufacturers Table 4. 400IU/Bottle Human Hepatitis B Immunoglobulin Major Manufacturers Table 5. Global Human Hepatitis B Immunoglobulin (HBIG) Market Size Growth Rate by Application (US$ Million), 2021 VS 2025 VS 2032 Table 6. Close Contacts of Patients with Hepatitis B and Hepatitis B Virus Carriers Major Manufacturers Table 7. Positive Infants Born to Mothers With Hepatitis B Surface Antigen(HBsAg) Major Manufacturers Table 8. Unexpected Crowd of Hepatitis B Infection Major Manufacturers Table 9. Human Hepatitis B Immunoglobulin (HBIG) Industry Trends Table 10. Human Hepatitis B Immunoglobulin (HBIG) Industry Drivers Table 11. Human Hepatitis B Immunoglobulin (HBIG) Industry Opportunities and Challenges Table 12. Human Hepatitis B Immunoglobulin (HBIG) Industry Restraints Table 13. Global Human Hepatitis B Immunoglobulin (HBIG) Revenue Grow Rate (CAGR) by Region: 2021 VS 2025 VS 2032 (US$ Million) Table 14. Global Human Hepatitis B Immunoglobulin (HBIG) Revenue by Region (2021-2026) & (US$ Million) Table 15. Global Human Hepatitis B Immunoglobulin (HBIG) Revenue by Region (2027-2032) & (US$ Million) Table 16. Global Human Hepatitis B Immunoglobulin (HBIG) Revenue Market Share by Region (2021-2026) Table 17. Global Human Hepatitis B Immunoglobulin (HBIG) Revenue Market Share by Region (2027-2032) Table 18. Global Human Hepatitis B Immunoglobulin (HBIG) Sales Grow Rate (CAGR) by Region: 2021 VS 2025 VS 2032 (K Units) Table 19. Global Human Hepatitis B Immunoglobulin (HBIG) Sales by Region (2021-2026) & (K Units) Table 20. Global Human Hepatitis B Immunoglobulin (HBIG) Sales by Region (2027-2032) & (K Units) Table 21. Global Human Hepatitis B Immunoglobulin (HBIG) Sales Market Share by Region (2021-2026) Table 22. Global Human Hepatitis B Immunoglobulin (HBIG) Sales Market Share by Region (2027-2032) Table 23. Global Human Hepatitis B Immunoglobulin (HBIG) Revenue by Manufacturers (US$ Million) & (2021-2026) Table 24. Global Human Hepatitis B Immunoglobulin (HBIG) Revenue Market Share by Manufacturers (2021-2026) Table 25. Global Human Hepatitis B Immunoglobulin (HBIG) Sales by Manufacturers (US$ Million) & (2021-2026) Table 26. Global Human Hepatitis B Immunoglobulin (HBIG) Sales Market Share by Manufacturers (2021-2026) Table 27. Global Human Hepatitis B Immunoglobulin (HBIG) Sales Price (US$/Unit) of Manufacturers (2021-2026) Table 28. Global Human Hepatitis B Immunoglobulin (HBIG) Key Manufacturers Ranking, 2024 VS 2025 VS 2026 Table 29. Global Human Hepatitis B Immunoglobulin (HBIG) Key Manufacturers Manufacturing Sites & Headquarters Table 30. Global Human Hepatitis B Immunoglobulin (HBIG) Manufacturers, Product Type & Application Table 31. Global Human Hepatitis B Immunoglobulin (HBIG) Manufacturers' Establishment Date Table 32. Global Manufacturers Market Concentration Ratio (CR5 and HHI) Table 33. Global Human Hepatitis B Immunoglobulin (HBIG) by Manufacturers Type (Tier 1, Tier 2, and Tier 3) & (Based on the Revenue of 2025) Table 34. Global Human Hepatitis B Immunoglobulin (HBIG) Revenue by Type 2021 VS 2025 VS 2032 (US$ Million) Table 35. Global Human Hepatitis B Immunoglobulin (HBIG) Revenue by Type (2021-2026) & (US$ Million) Table 36. Global Human Hepatitis B Immunoglobulin (HBIG) Revenue by Type (2027-2032) & (US$ Million) Table 37. Global Human Hepatitis B Immunoglobulin (HBIG) Revenue Market Share by Type (2021-2026) Table 38. Global Human Hepatitis B Immunoglobulin (HBIG) Revenue Market Share by Type (2027-2032) Table 39. Global Human Hepatitis B Immunoglobulin (HBIG) Sales by Type 2021 VS 2025 VS 2032 (K Units) Table 40. Global Human Hepatitis B Immunoglobulin (HBIG) Sales by Type (2021-2026) & (K Units) Table 41. Global Human Hepatitis B Immunoglobulin (HBIG) Sales by Type (2027-2032) & (K Units) Table 42. Global Human Hepatitis B Immunoglobulin (HBIG) Sales Market Share by Type (2021-2026) Table 43. Global Human Hepatitis B Immunoglobulin (HBIG) Sales Market Share by Type (2027-2032) Table 44. Global Human Hepatitis B Immunoglobulin (HBIG) Price by Type (2021-2026) & (US$/Unit) Table 45. Global Human Hepatitis B Immunoglobulin (HBIG) Price by Type (2027-2032) & (US$/Unit) Table 46. Global Human Hepatitis B Immunoglobulin (HBIG) Revenue by Application 2021 VS 2025 VS 2032 (US$ Million) Table 47. Global Human Hepatitis B Immunoglobulin (HBIG) Revenue by Application (2021-2026) & (US$ Million) Table 48. Global Human Hepatitis B Immunoglobulin (HBIG) Revenue by Application (2027-2032) & (US$ Million) Table 49. Global Human Hepatitis B Immunoglobulin (HBIG) Revenue Market Share by Application (2021-2026) Table 50. Global Human Hepatitis B Immunoglobulin (HBIG) Revenue Market Share by Application (2027-2032) Table 51. Global Human Hepatitis B Immunoglobulin (HBIG) Sales by Application 2021 VS 2025 VS 2032 (K Units) Table 52. Global Human Hepatitis B Immunoglobulin (HBIG) Sales by Application (2021-2026) & (K Units) Table 53. Global Human Hepatitis B Immunoglobulin (HBIG) Sales by Application (2027-2032) & (K Units) Table 54. Global Human Hepatitis B Immunoglobulin (HBIG) Sales Market Share by Application (2021-2026) Table 55. Global Human Hepatitis B Immunoglobulin (HBIG) Sales Market Share by Application (2027-2032) Table 56. Global Human Hepatitis B Immunoglobulin (HBIG) Price by Application (2021-2026) & (US$/Unit) Table 57. Global Human Hepatitis B Immunoglobulin (HBIG) Price by Application (2027-2032) & (US$/Unit) Table 58. Boya Bio-pharmaceutical Company Information Table 59. Boya Bio-pharmaceutical Business Overview Table 60. Boya Bio-pharmaceutical Human Hepatitis B Immunoglobulin (HBIG) Sales (K Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2021-2026) Table 61. Boya Bio-pharmaceutical Human Hepatitis B Immunoglobulin (HBIG) Product Portfolio Table 62. Boya Bio-pharmaceutical Recent Development Table 63. CSL Company Information Table 64. CSL Business Overview Table 65. CSL Human Hepatitis B Immunoglobulin (HBIG) Sales (K Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2021-2026) Table 66. CSL Human Hepatitis B Immunoglobulin (HBIG) Product Portfolio Table 67. CSL Recent Development Table 68. Grifols Company Information Table 69. Grifols Business Overview Table 70. Grifols Human Hepatitis B Immunoglobulin (HBIG) Sales (K Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2021-2026) Table 71. Grifols Human Hepatitis B Immunoglobulin (HBIG) Product Portfolio Table 72. Grifols Recent Development Table 73. Octapharma Company Information Table 74. Octapharma Business Overview Table 75. Octapharma Human Hepatitis B Immunoglobulin (HBIG) Sales (K Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2021-2026) Table 76. Octapharma Human Hepatitis B Immunoglobulin (HBIG) Product Portfolio Table 77. Octapharma Recent Development Table 78. Baxter Company Information Table 79. Baxter Business Overview Table 80. Baxter Human Hepatitis B Immunoglobulin (HBIG) Sales (K Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2021-2026) Table 81. Baxter Human Hepatitis B Immunoglobulin (HBIG) Product Portfolio Table 82. Baxter Recent Development Table 83. Bayer Company Information Table 84. Bayer Business Overview Table 85. Bayer Human Hepatitis B Immunoglobulin (HBIG) Sales (K Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2021-2026) Table 86. Bayer Human Hepatitis B Immunoglobulin (HBIG) Product Portfolio Table 87. Bayer Recent Development Table 88. Tiantan Biologic Company Information Table 89. Tiantan Biologic Business Overview Table 90. Tiantan Biologic Human Hepatitis B Immunoglobulin (HBIG) Sales (K Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2021-2026) Table 91. Tiantan Biologic Human Hepatitis B Immunoglobulin (HBIG) Product Portfolio Table 92. Tiantan Biologic Recent Development Table 93. Shuanglin Bio-pharmacy Company Information Table 94. Shuanglin Bio-pharmacy Business Overview Table 95. Shuanglin Bio-pharmacy Human Hepatitis B Immunoglobulin (HBIG) Sales (K Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2021-2026) Table 96. Shuanglin Bio-pharmacy Human Hepatitis B Immunoglobulin (HBIG) Product Portfolio Table 97. Shuanglin Bio-pharmacy Recent Development Table 98. Hualan Biological Company Information Table 99. Hualan Biological Business Overview Table 100. Hualan Biological Human Hepatitis B Immunoglobulin (HBIG) Sales (K Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2021-2026) Table 101. Hualan Biological Human Hepatitis B Immunoglobulin (HBIG) Product Portfolio Table 102. Hualan Biological Recent Development Table 103. Shanghai RAAS Company Information Table 104. Shanghai RAAS Business Overview Table 105. Shanghai RAAS Human Hepatitis B Immunoglobulin (HBIG) Sales (K Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2021-2026) Table 106. Shanghai RAAS Human Hepatitis B Immunoglobulin (HBIG) Product Portfolio Table 107. Shanghai RAAS Recent Development Table 108. Sichuan Yuanda Shuyang Company Information Table 109. Sichuan Yuanda Shuyang Business Overview Table 110. Sichuan Yuanda Shuyang Human Hepatitis B Immunoglobulin (HBIG) Sales (K Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2021-2026) Table 111. Sichuan Yuanda Shuyang Human Hepatitis B Immunoglobulin (HBIG) Product Portfolio Table 112. Sichuan Yuanda Shuyang Recent Development Table 113. China Biologic Company Information Table 114. China Biologic Business Overview Table 115. China Biologic Human Hepatitis B Immunoglobulin (HBIG) Sales (K Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2021-2026) Table 116. China Biologic Human Hepatitis B Immunoglobulin (HBIG) Product Portfolio Table 117. China Biologic Recent Development Table 118. Shanghai Institute of Biological Company Information Table 119. Shanghai Institute of Biological Business Overview Table 120. Shanghai Institute of Biological Human Hepatitis B Immunoglobulin (HBIG) Sales (K Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2021-2026) Table 121. Shanghai Institute of Biological Human Hepatitis B Immunoglobulin (HBIG) Product Portfolio Table 122. Shanghai Institute of Biological Recent Development Table 123. North America Human Hepatitis B Immunoglobulin (HBIG) Revenue by Type (2021-2026) & (US$ Million) Table 124. North America Human Hepatitis B Immunoglobulin (HBIG) Revenue by Type (2027-2032) & (US$ Million) Table 125. North America Human Hepatitis B Immunoglobulin (HBIG) Sales by Type (2021-2026) & (K Units) Table 126. North America Human Hepatitis B Immunoglobulin (HBIG) Sales by Type (2027-2032) & (K Units) Table 127. North America Human Hepatitis B Immunoglobulin (HBIG) Sales Price by Type (2021-2026) & (US$/Unit) Table 128. North America Human Hepatitis B Immunoglobulin (HBIG) Sales Price by Type (2027-2032) & (US$/Unit) Table 129. North America Human Hepatitis B Immunoglobulin (HBIG) Revenue by Application (2021-2026) & (US$ Million) Table 130. North America Human Hepatitis B Immunoglobulin (HBIG) Revenue by Application (2027-2032) & (US$ Million) Table 131. North America Human Hepatitis B Immunoglobulin (HBIG) Sales by Application (2021-2026) & (K Units) Table 132. North America Human Hepatitis B Immunoglobulin (HBIG) Sales by Application (2027-2032) & (K Units) Table 133. North America Human Hepatitis B Immunoglobulin (HBIG) Sales Price by Application (2021-2026) & (US$/Unit) Table 134. North America Human Hepatitis B Immunoglobulin (HBIG) Sales Price by Application (2027-2032) & (US$/Unit) Table 135. North America Human Hepatitis B Immunoglobulin (HBIG) Revenue Grow Rate by Country (2021 VS 2025 VS 2032) & (US$ Million) Table 136. North America Human Hepatitis B Immunoglobulin (HBIG) Revenue Grow Rate by Country (2021-2026) & (US$ Million) Table 137. North America Human Hepatitis B Immunoglobulin (HBIG) Revenue Grow Rate by Country (2027-2032) & (US$ Million) Table 138. North America Human Hepatitis B Immunoglobulin (HBIG) Sales by Country (2021 VS 2025 VS 2032) & (K Units) Table 139. North America Human Hepatitis B Immunoglobulin (HBIG) Sales by Country (2021-2026) & (K Units) Table 140. North America Human Hepatitis B Immunoglobulin (HBIG) Sales by Country (2027-2032) & (K Units) Table 141. North America Human Hepatitis B Immunoglobulin (HBIG) Sales Price by Country (2021-2026) & (US$/Unit) Table 142. North America Human Hepatitis B Immunoglobulin (HBIG) Sales Price by Country (2027-2032) & (US$/Unit) Table 143. United States Human Hepatitis B Immunoglobulin (HBIG) Revenue (2021-2032) & (US$ Million) Table 144. Canada Human Hepatitis B Immunoglobulin (HBIG) Revenue (2021-2032) & (US$ Million) Table 145. Mexico Human Hepatitis B Immunoglobulin (HBIG) Revenue (2021-2032) & (US$ Million) Table 146. Europe Human Hepatitis B Immunoglobulin (HBIG) Revenue by Type (2021-2026) & (US$ Million) Table 147. Europe Human Hepatitis B Immunoglobulin (HBIG) Revenue by Type (2027-2032) & (US$ Million) Table 148. Europe Human Hepatitis B Immunoglobulin (HBIG) Sales by Type (2021-2026) & (K Units) Table 149. Europe Human Hepatitis B Immunoglobulin (HBIG) Sales by Type (2027-2032) & (K Units) Table 150. Europe Human Hepatitis B Immunoglobulin (HBIG) Sales Price by Type (2021-2026) & (US$/Unit) Table 151. Europe Human Hepatitis B Immunoglobulin (HBIG) Sales Price by Type (2027-2032) & (US$/Unit) Table 152. Europe Human Hepatitis B Immunoglobulin (HBIG) Revenue by Application (2021-2026) & (US$ Million) Table 153. Europe Human Hepatitis B Immunoglobulin (HBIG) Revenue by Application (2027-2032) & (US$ Million) Table 154. Europe Human Hepatitis B Immunoglobulin (HBIG) Sales by Application (2021-2026) & (K Units) Table 155. Europe Human Hepatitis B Immunoglobulin (HBIG) Sales by Application (2027-2032) & (K Units) Table 156. Europe Human Hepatitis B Immunoglobulin (HBIG) Sales Price by Application (2021-2026) & (US$/Unit) Table 157. Europe Human Hepatitis B Immunoglobulin (HBIG) Sales Price by Application (2027-2032) & (US$/Unit) Table 158. Europe Human Hepatitis B Immunoglobulin (HBIG) Revenue Grow Rate by Country (2021 VS 2025 VS 2032) & (US$ Million) Table 159. Europe Human Hepatitis B Immunoglobulin (HBIG) Revenue Grow Rate by Country (2021-2026) & (US$ Million) Table 160. Europe Human Hepatitis B Immunoglobulin (HBIG) Revenue Grow Rate by Country (2027-2032) & (US$ Million) Table 161. Europe Human Hepatitis B Immunoglobulin (HBIG) Sales by Country (2021 VS 2025 VS 2032) & (K Units) Table 162. Europe Human Hepatitis B Immunoglobulin (HBIG) Sales by Country (2021-2026) & (K Units) Table 163. Europe Human Hepatitis B Immunoglobulin (HBIG) Sales by Country (2027-2032) & (K Units) Table 164. Europe Human Hepatitis B Immunoglobulin (HBIG) Sales Price by Country (2021-2026) & (US$/Unit) Table 165. Europe Human Hepatitis B Immunoglobulin (HBIG) Sales Price by Country (2027-2032) & (US$/Unit) Table 166. Germany Human Hepatitis B Immunoglobulin (HBIG) Revenue (2021-2032) & (US$ Million) Table 167. France Human Hepatitis B Immunoglobulin (HBIG) Revenue (2021-2032) & (US$ Million) Table 168. U.K. Human Hepatitis B Immunoglobulin (HBIG) Revenue (2021-2032) & (US$ Million) Table 169. Italy Human Hepatitis B Immunoglobulin (HBIG) Revenue (2021-2032) & (US$ Million) Table 170. Russia Human Hepatitis B Immunoglobulin (HBIG) Revenue (2021-2032) & (US$ Million) Table 171. Spain Human Hepatitis B Immunoglobulin (HBIG) Revenue (2021-2032) & (US$ Million) Table 172. Netherlands Human Hepatitis B Immunoglobulin (HBIG) Revenue (2021-2032) & (US$ Million) Table 173. Switzerland Human Hepatitis B Immunoglobulin (HBIG) Revenue (2021-2032) & (US$ Million) Table 174. Sweden Human Hepatitis B Immunoglobulin (HBIG) Revenue (2021-2032) & (US$ Million) Table 175. Poland Human Hepatitis B Immunoglobulin (HBIG) Revenue (2021-2032) & (US$ Million) Table 176. China Human Hepatitis B Immunoglobulin (HBIG) Revenue by Type (2021-2026) & (US$ Million) Table 177. China Human Hepatitis B Immunoglobulin (HBIG) Revenue by Type (2027-2032) & (US$ Million) Table 178. China Human Hepatitis B Immunoglobulin (HBIG) Sales by Type (2021-2026) & (K Units) Table 179. China Human Hepatitis B Immunoglobulin (HBIG) Sales by Type (2027-2032) & (K Units) Table 180. China Human Hepatitis B Immunoglobulin (HBIG) Sales Price by Type (2021-2026) & (US$/Unit) Table 181. China Human Hepatitis B Immunoglobulin (HBIG) Sales Price by Type (2027-2032) & (US$/Unit) Table 182. China Human Hepatitis B Immunoglobulin (HBIG) Revenue by Application (2021-2026) & (US$ Million) Table 183. China Human Hepatitis B Immunoglobulin (HBIG) Revenue by Application (2027-2032) & (US$ Million) Table 184. China Human Hepatitis B Immunoglobulin (HBIG) Sales by Application (2021-2026) & (K Units) Table 185. China Human Hepatitis B Immunoglobulin (HBIG) Sales by Application (2027-2032) & (K Units) Table 186. China Human Hepatitis B Immunoglobulin (HBIG) Sales Price by Application (2021-2026) & (US$/Unit) Table 187. China Human Hepatitis B Immunoglobulin (HBIG) Sales Price by Application (2027-2032) & (US$/Unit) Table 188. Asia Human Hepatitis B Immunoglobulin (HBIG) Revenue by Type (2021-2026) & (US$ Million) Table 189. Asia Human Hepatitis B Immunoglobulin (HBIG) Revenue by Type (2027-2032) & (US$ Million) Table 190. Asia Human Hepatitis B Immunoglobulin (HBIG) Sales by Type (2021-2026) & (K Units) Table 191. Asia Human Hepatitis B Immunoglobulin (HBIG) Sales by Type (2027-2032) & (K Units) Table 192. Asia Human Hepatitis B Immunoglobulin (HBIG) Sales Price by Type (2021-2026) & (US$/Unit) Table 193. Asia Human Hepatitis B Immunoglobulin (HBIG) Sales Price by Type (2027-2032) & (US$/Unit) Table 194. Asia Human Hepatitis B Immunoglobulin (HBIG) Revenue by Application (2021-2026) & (US$ Million) Table 195. Asia Human Hepatitis B Immunoglobulin (HBIG) Revenue by Application (2027-2032) & (US$ Million) Table 196. Asia Human Hepatitis B Immunoglobulin (HBIG) Sales by Application (2021-2026) & (K Units) Table 197. Asia Human Hepatitis B Immunoglobulin (HBIG) Sales by Application (2027-2032) & (K Units) Table 198. Asia Human Hepatitis B Immunoglobulin (HBIG) Sales Price by Application (2021-2026) & (US$/Unit) Table 199. Asia Human Hepatitis B Immunoglobulin (HBIG) Sales Price by Application (2027-2032) & (US$/Unit) Table 200. Asia Human Hepatitis B Immunoglobulin (HBIG) Revenue Grow Rate by Country (2021 VS 2025 VS 2032) & (US$ Million) Table 201. Asia Human Hepatitis B Immunoglobulin (HBIG) Revenue Grow Rate by Country (2021-2026) & (US$ Million) Table 202. Asia Human Hepatitis B Immunoglobulin (HBIG) Revenue Grow Rate by Country (2027-2032) & (US$ Million) Table 203. Asia Human Hepatitis B Immunoglobulin (HBIG) Sales by Country (2021 VS 2025 VS 2032) & (K Units) Table 204. Asia Human Hepatitis B Immunoglobulin (HBIG) Sales by Country (2021-2026) & (K Units) Table 205. Asia Human Hepatitis B Immunoglobulin (HBIG) Sales by Country (2027-2032) & (K Units) Table 206. Asia Human Hepatitis B Immunoglobulin (HBIG) Sales Price by Country (2021-2026) & (US$/Unit) Table 207. Asia Human Hepatitis B Immunoglobulin (HBIG) Sales Price by Country (2027-2032) & (US$/Unit) Table 208. Japan Human Hepatitis B Immunoglobulin (HBIG) Revenue (2021-2032) & (US$ Million) Table 209. South Korea Human Hepatitis B Immunoglobulin (HBIG) Revenue (2021-2032) & (US$ Million) Table 210. India Human Hepatitis B Immunoglobulin (HBIG) Revenue (2021-2032) & (US$ Million) Table 211. Australia Human Hepatitis B Immunoglobulin (HBIG) Revenue (2021-2032) & (US$ Million) Table 212. Taiwan Human Hepatitis B Immunoglobulin (HBIG) Revenue (2021-2032) & (US$ Million) Table 213. Southeast Asia Human Hepatitis B Immunoglobulin (HBIG) Revenue (2021-2032) & (US$ Million) Table 214. SAMEA Human Hepatitis B Immunoglobulin (HBIG) Revenue by Type (2021-2026) & (US$ Million) Table 215. SAMEA Human Hepatitis B Immunoglobulin (HBIG) Revenue by Type (2027-2032) & (US$ Million) Table 216. SAMEA Human Hepatitis B Immunoglobulin (HBIG) Sales by Type (2021-2026) & (K Units) Table 217. SAMEA Human Hepatitis B Immunoglobulin (HBIG) Sales by Type (2027-2032) & (K Units) Table 218. SAMEA Human Hepatitis B Immunoglobulin (HBIG) Sales Price by Type (2021-2026) & (US$/Unit) Table 219. SAMEA Human Hepatitis B Immunoglobulin (HBIG) Sales Price by Type (2027-2032) & (US$/Unit) Table 220. SAMEA Human Hepatitis B Immunoglobulin (HBIG) Revenue by Application (2021-2026) & (US$ Million) Table 221. SAMEA Human Hepatitis B Immunoglobulin (HBIG) Revenue by Application (2027-2032) & (US$ Million) Table 222. SAMEA Human Hepatitis B Immunoglobulin (HBIG) Sales by Application (2021-2026) & (K Units) Table 223. SAMEA Human Hepatitis B Immunoglobulin (HBIG) Sales by Application (2027-2032) & (K Units) Table 224. SAMEA Human Hepatitis B Immunoglobulin (HBIG) Sales Price by Application (2021-2026) & (US$/Unit) Table 225. SAMEA Human Hepatitis B Immunoglobulin (HBIG) Sales Price by Application (2027-2032) & (US$/Unit) Table 226. SAMEA Human Hepatitis B Immunoglobulin (HBIG) Revenue Grow Rate by Country (2021 VS 2025 VS 2032) & (US$ Million) Table 227. SAMEA Human Hepatitis B Immunoglobulin (HBIG) Revenue Grow Rate by Country (2021-2026) & (US$ Million) Table 228. SAMEA Human Hepatitis B Immunoglobulin (HBIG) Revenue Grow Rate by Country (2027-2032) & (US$ Million) Table 229. SAMEA Human Hepatitis B Immunoglobulin (HBIG) Sales by Country (2021 VS 2025 VS 2032) & (K Units) Table 230. SAMEA Human Hepatitis B Immunoglobulin (HBIG) Sales by Country (2021-2026) & (K Units) Table 231. SAMEA Human Hepatitis B Immunoglobulin (HBIG) Sales by Country (2027-2032) & (K Units) Table 232. SAMEA Human Hepatitis B Immunoglobulin (HBIG) Sales Price by Country (2021-2026) & (US$/Unit) Table 233. SAMEA Human Hepatitis B Immunoglobulin (HBIG) Sales Price by Country (2027-2032) & (US$/Unit) Table 234. Brazil Human Hepatitis B Immunoglobulin (HBIG) Revenue (2021-2032) & (US$ Million) Table 235. Argentina Human Hepatitis B Immunoglobulin (HBIG) Revenue (2021-2032) & (US$ Million) Table 236. Chile Human Hepatitis B Immunoglobulin (HBIG) Revenue (2021-2032) & (US$ Million) Table 237. Colombia Human Hepatitis B Immunoglobulin (HBIG) Revenue (2021-2032) & (US$ Million) Table 238. Peru Human Hepatitis B Immunoglobulin (HBIG) Revenue (2021-2032) & (US$ Million) Table 239. Saudi Arabia Human Hepatitis B Immunoglobulin (HBIG) Revenue (2021-2032) & (US$ Million) Table 240. Israel Human Hepatitis B Immunoglobulin (HBIG) Revenue (2021-2032) & (US$ Million) Table 241. UAE Human Hepatitis B Immunoglobulin (HBIG) Revenue (2021-2032) & (US$ Million) Table 242. Turkey Human Hepatitis B Immunoglobulin (HBIG) Revenue (2021-2032) & (US$ Million) Table 243. Iran Human Hepatitis B Immunoglobulin (HBIG) Revenue (2021-2032) & (US$ Million) Table 244. Egypt Human Hepatitis B Immunoglobulin (HBIG) Revenue (2021-2032) & (US$ Million) Table 245. Key Raw Materials Table 246. Raw Materials Key Suppliers Table 247. Human Hepatitis B Immunoglobulin (HBIG) Distributors List Table 248. Human Hepatitis B Immunoglobulin (HBIG) Customers List Table 249. Research Programs/Design for This Report Table 250. Authors List of This Report Table 251. Secondary Sources Table 252. Primary Sources List of Figures Figure 1. Human Hepatitis B Immunoglobulin (HBIG) Image Figure 2. Global Human Hepatitis B Immunoglobulin (HBIG) Market Size Growth Rate by Type (US$ Million), 2021 VS 2025 VS 2032 Figure 3. Global Human Hepatitis B Immunoglobulin (HBIG) Market Size Share 2021 VS 2025 VS 2032 Figure 4. 100IU/Bottle Human Hepatitis B Immunoglobulin Image Figure 5. 200IU/Bottle Human Hepatitis B Immunoglobulin Image Figure 6. 400IU/Bottle Human Hepatitis B Immunoglobulin Image Figure 7. Global Human Hepatitis B Immunoglobulin (HBIG) Market Size Growth Rate by Application (US$ Million), 2021 VS 2025 VS 2032 Figure 8. Global Human Hepatitis B Immunoglobulin (HBIG) Market Size Share 2021 VS 2025 VS 2032 Figure 9. Close Contacts of Patients with Hepatitis B and Hepatitis B Virus Carriers Image Figure 10. Positive Infants Born to Mothers With Hepatitis B Surface Antigen(HBsAg) Image Figure 11. Unexpected Crowd of Hepatitis B Infection Image Figure 12. Global Human Hepatitis B Immunoglobulin (HBIG) Revenue (US$ Million), 2021 VS 2025 VS 2032 Figure 13. Global Human Hepatitis B Immunoglobulin (HBIG) Revenue (2021-2032) & (US$ Million) Figure 14. Global Human Hepatitis B Immunoglobulin (HBIG) Revenue (CAGR) by Region: 2021 VS 2025 VS 2032 (US$ Million) Figure 15. Global Human Hepatitis B Immunoglobulin (HBIG) Revenue Market Share by Region: 2025 Versus 2032 Figure 16. Global Human Hepatitis B Immunoglobulin (HBIG) Revenue Market Share by Region (2021-2032) Figure 17. Global Human Hepatitis B Immunoglobulin (HBIG) Sales (2021-2032) & (K Units) Figure 18. Global Human Hepatitis B Immunoglobulin (HBIG) Sales by Region: 2021 VS 2025 VS 2032 (K Units) Figure 19. Global Human Hepatitis B Immunoglobulin (HBIG) Sales Market Share by Region (2021-2032) Figure 20. US & Canada & Mexico Human Hepatitis B Immunoglobulin (HBIG) Sales YoY (2021-2032) & (K Units) Figure 21. Europe Human Hepatitis B Immunoglobulin (HBIG) Sales YoY (2021-2032) & (K Units) Figure 22. China Human Hepatitis B Immunoglobulin (HBIG) Sales YoY (2021-2032) & (K Units) Figure 23. Asia (Excluding China) Human Hepatitis B Immunoglobulin (HBIG) Sales YoY (2021-2032) & (K Units) Figure 24. South America, Middle East and Africa Human Hepatitis B Immunoglobulin (HBIG) Sales YoY (2021-2032) & (K Units) Figure 25. Global Human Hepatitis B Immunoglobulin (HBIG) Manufacturers Revenue Share Top 10 and Top 5 in 2025 Figure 26. Global Human Hepatitis B Immunoglobulin (HBIG) Manufacturers Sales Share Top 10 and Top 5 in 2025 Figure 27. Manufacturers Type (Tier 1, Tier 2, and Tier 3): 2021 VS 2025 Figure 28. Global Human Hepatitis B Immunoglobulin (HBIG) Revenue by Type (2021 VS 2025 VS 2032) & (US$ Million) Figure 29. Global Human Hepatitis B Immunoglobulin (HBIG) Revenue Market Share by Type 2021 VS 2025 VS 2032 Figure 30. Global Human Hepatitis B Immunoglobulin (HBIG) Revenue Market Share by Type (2021-2032) Figure 31. Global Human Hepatitis B Immunoglobulin (HBIG) Sales by Type (2021 VS 2025 VS 2032) & (K Units) Figure 32. Global Human Hepatitis B Immunoglobulin (HBIG) Sales Market Share by Type 2021 VS 2025 VS 2032 Figure 33. Global Human Hepatitis B Immunoglobulin (HBIG) Sales Market Share by Type (2021-2032) Figure 34. Global Human Hepatitis B Immunoglobulin (HBIG) Revenue by Application (2021 VS 2025 VS 2032) & (US$ Million) Figure 35. Global Human Hepatitis B Immunoglobulin (HBIG) Revenue Market Share by Application 2021 VS 2025 VS 2032 Figure 36. Global Human Hepatitis B Immunoglobulin (HBIG) Revenue Market Share by Application (2021-2032) Figure 37. Global Human Hepatitis B Immunoglobulin (HBIG) Sales by Application (2021 VS 2025 VS 2032) & (K Units) Figure 38. Global Human Hepatitis B Immunoglobulin (HBIG) Sales Market Share by Application 2021 VS 2025 VS 2032 Figure 39. Global Human Hepatitis B Immunoglobulin (HBIG) Sales Market Share by Application (2021-2032) Figure 40. North America Human Hepatitis B Immunoglobulin (HBIG) Revenue Share by Type (2021-2032) Figure 41. North America Human Hepatitis B Immunoglobulin (HBIG) Sales Share by Type (2021-2032) Figure 42. North America Human Hepatitis B Immunoglobulin (HBIG) Revenue Share by Application (2021-2032) Figure 43. North America Human Hepatitis B Immunoglobulin (HBIG) Sales Share by Application (2021-2032) Figure 44. North America Human Hepatitis B Immunoglobulin (HBIG) Revenue Share by Country (2021-2032) Figure 45. North America Human Hepatitis B Immunoglobulin (HBIG) Sales Share by Country (2021-2032) Figure 46. Europe Human Hepatitis B Immunoglobulin (HBIG) Revenue Share by Type (2021-2032) Figure 47. Europe Human Hepatitis B Immunoglobulin (HBIG) Sales Share by Type (2021-2032) Figure 48. Europe Human Hepatitis B Immunoglobulin (HBIG) Revenue Share by Application (2021-2032) Figure 49. Europe Human Hepatitis B Immunoglobulin (HBIG) Sales Share by Application (2021-2032) Figure 50. Europe Human Hepatitis B Immunoglobulin (HBIG) Revenue Share by Country (2021-2032) Figure 51. Europe Human Hepatitis B Immunoglobulin (HBIG) Sales Share by Country (2021-2032) Figure 52. China Human Hepatitis B Immunoglobulin (HBIG) Revenue Share by Type (2021-2032) Figure 53. China Human Hepatitis B Immunoglobulin (HBIG) Sales Share by Type (2021-2032) Figure 54. China Human Hepatitis B Immunoglobulin (HBIG) Revenue Share by Application (2021-2032) Figure 55. China Human Hepatitis B Immunoglobulin (HBIG) Sales Share by Application (2021-2032) Figure 56. Asia Human Hepatitis B Immunoglobulin (HBIG) Revenue Share by Type (2021-2032) Figure 57. Asia Human Hepatitis B Immunoglobulin (HBIG) Sales Share by Type (2021-2032) Figure 58. Asia Human Hepatitis B Immunoglobulin (HBIG) Revenue Share by Application (2021-2032) Figure 59. Asia Human Hepatitis B Immunoglobulin (HBIG) Sales Share by Application (2021-2032) Figure 60. Asia Human Hepatitis B Immunoglobulin (HBIG) Revenue Share by Country (2021-2032) Figure 61. Asia Human Hepatitis B Immunoglobulin (HBIG) Sales Share by Country (2021-2032) Figure 62. SAMEA Human Hepatitis B Immunoglobulin (HBIG) Revenue Share by Type (2021-2032) Figure 63. SAMEA Human Hepatitis B Immunoglobulin (HBIG) Sales Share by Type (2021-2032) Figure 64. SAMEA Human Hepatitis B Immunoglobulin (HBIG) Revenue Share by Application (2021-2032) Figure 65. SAMEA Human Hepatitis B Immunoglobulin (HBIG) Sales Share by Application (2021-2032) Figure 66. SAMEA Human Hepatitis B Immunoglobulin (HBIG) Revenue Share by Country (2021-2032) Figure 67. SAMEA Human Hepatitis B Immunoglobulin (HBIG) Sales Share by Country (2021-2032) Figure 68. Human Hepatitis B Immunoglobulin (HBIG) Value Chain Figure 69. Manufacturing Cost Structure Figure 70. Human Hepatitis B Immunoglobulin (HBIG) Production Mode & Process Figure 71. Direct Comparison with Distribution Share Figure 72. Distributors Profiles Figure 73. Years Considered Figure 74. Research Process Figure 75. Key Executives Interviewed

Scope & coverage.

Types
  • 100IU/Bottle Human Hepatitis B Immunoglobulin
  • 200IU/Bottle Human Hepatitis B Immunoglobulin
  • 400IU/Bottle Human Hepatitis B Immunoglobulin
Applications
  • Close Contacts of Patients with Hepatitis B and Hepatitis B Virus Carriers
  • Positive Infants Born to Mothers With Hepatitis B Surface Antigen(HBsAg)
  • Unexpected Crowd of Hepatitis B Infection
Companies covered
  • Boya Bio-pharmaceutical
  • CSL
  • Grifols
  • Octapharma
  • Baxter
  • Bayer
  • Tiantan Biologic
  • Shuanglin Bio-pharmacy
  • Hualan Biological
  • Shanghai RAAS
  • Sichuan Yuanda Shuyang
  • China Biologic
  • Shanghai Institute of Biological

Inside the report.

1 Market Overview
  1. 1.1 Product Definition
  2. 1.2 Human Hepatitis B Immunoglobulin (HBIG) Market by Type
  3. 1.2.1 Global Human Hepatitis B Immunoglobulin (HBIG) Market Size by Type, 2021 VS 2025 VS 2032
  4. 1.2.2 100IU/Bottle Human Hepatitis B Immunoglobulin
  5. 1.2.3 200IU/Bottle Human Hepatitis B Immunoglobulin
  6. 1.2.4 400IU/Bottle Human Hepatitis B Immunoglobulin
  7. 1.3 Human Hepatitis B Immunoglobulin (HBIG) Market by Application
  8. 1.3.1 Global Human Hepatitis B Immunoglobulin (HBIG) Market Size by Application, 2021 VS 2025 VS 2032
  9. 1.3.2 Close Contacts of Patients with Hepatitis B and Hepatitis B Virus Carriers
  10. 1.3.3 Positive Infants Born to Mothers With Hepatitis B Surface Antigen(HBsAg)
  11. 1.3.4 Unexpected Crowd of Hepatitis B Infection
  12. 1.4 Assumptions and Limitations
  13. 1.5 Study Goals and Objectives
2 Human Hepatitis B Immunoglobulin (HBIG) Market Dynamics
  1. 2.1 Human Hepatitis B Immunoglobulin (HBIG) Industry Trends
  2. 2.2 Human Hepatitis B Immunoglobulin (HBIG) Industry Drivers
  3. 2.3 Human Hepatitis B Immunoglobulin (HBIG) Industry Opportunities and Challenges
  4. 2.4 Human Hepatitis B Immunoglobulin (HBIG) Industry Restraints
3 Global Market Growth Prospects
  1. 3.1 Global Human Hepatitis B Immunoglobulin (HBIG) Revenue Estimates and Forecasts (2021-2032)
  2. 3.2 Global Human Hepatitis B Immunoglobulin (HBIG) Revenue by Region
  3. 3.2.1 Global Human Hepatitis B Immunoglobulin (HBIG) Revenue by Region: 2021 VS 2025 VS 2032
  4. 3.2.2 Global Human Hepatitis B Immunoglobulin (HBIG) Revenue by Region (2021-2026)
  5. 3.2.3 Global Human Hepatitis B Immunoglobulin (HBIG) Revenue by Region (2027-2032)
  6. 3.2.4 Global Human Hepatitis B Immunoglobulin (HBIG) Revenue Market Share by Region (2021-2032)
  7. 3.3 Global Human Hepatitis B Immunoglobulin (HBIG) Sales Estimates and Forecasts 2021-2032
  8. 3.4 Global Human Hepatitis B Immunoglobulin (HBIG) Sales by Region
  9. 3.4.1 Global Human Hepatitis B Immunoglobulin (HBIG) Sales by Region: 2021 VS 2025 VS 2032
  10. 3.4.2 Global Human Hepatitis B Immunoglobulin (HBIG) Sales by Region (2021-2026)
  11. 3.4.3 Global Human Hepatitis B Immunoglobulin (HBIG) Sales by Region (2027-2032)
  12. 3.4.4 Global Human Hepatitis B Immunoglobulin (HBIG) Sales Market Share by Region (2021-2032)
  13. 3.5 US & Canada & Mexico
  14. 3.6 Europe
  15. 3.7 China
  16. 3.8 Asia (Excluding China)
  17. 3.9 South America, Middle East and Africa
4 Market Competitive Landscape by Manufacturers
  1. 4.1 Global Human Hepatitis B Immunoglobulin (HBIG) Revenue by Manufacturers
  2. 4.1.1 Global Human Hepatitis B Immunoglobulin (HBIG) Revenue by Manufacturers (2021-2026)
  3. 4.1.2 Global Human Hepatitis B Immunoglobulin (HBIG) Revenue Market Share by Manufacturers (2021-2026)
  4. 4.1.3 Global Human Hepatitis B Immunoglobulin (HBIG) Manufacturers Revenue Share Top 10 and Top 5 in 2025
  5. 4.2 Global Human Hepatitis B Immunoglobulin (HBIG) Sales by Manufacturers
  6. 4.2.1 Global Human Hepatitis B Immunoglobulin (HBIG) Sales by Manufacturers (2021-2026)
  7. 4.2.2 Global Human Hepatitis B Immunoglobulin (HBIG) Sales Market Share by Manufacturers (2021-2026)
  8. 4.2.3 Global Human Hepatitis B Immunoglobulin (HBIG) Manufacturers Sales Share Top 10 and Top 5 in 2025
  9. 4.3 Global Human Hepatitis B Immunoglobulin (HBIG) Sales Price by Manufacturers (2021-2026)
  10. 4.4 Global Human Hepatitis B Immunoglobulin (HBIG) Key Manufacturers Ranking, 2024 VS 2025 VS 2026
  11. 4.5 Global Human Hepatitis B Immunoglobulin (HBIG) Key Manufacturers Manufacturing Sites & Headquarters
  12. 4.6 Global Human Hepatitis B Immunoglobulin (HBIG) Manufacturers, Product Type & Application
  13. 4.7 Global Human Hepatitis B Immunoglobulin (HBIG) Manufacturers' Establishment Date
  14. 4.8 Market Competitive Analysis
  15. 4.8.1 Global Human Hepatitis B Immunoglobulin (HBIG) Market CR5 and HHI
  16. 4.8.2 2025 Human Hepatitis B Immunoglobulin (HBIG) Tier 1, Tier 2, and Tier 3
5 Human Hepatitis B Immunoglobulin (HBIG) Market by Type
  1. 5.1 Global Human Hepatitis B Immunoglobulin (HBIG) Revenue by Type
  2. 5.1.1 Global Human Hepatitis B Immunoglobulin (HBIG) Revenue by Type (2021 VS 2025 VS 2032)
  3. 5.1.2 Global Human Hepatitis B Immunoglobulin (HBIG) Revenue by Type (2021-2032) & (US$ Million)
  4. 5.1.3 Global Human Hepatitis B Immunoglobulin (HBIG) Revenue Market Share by Type (2021-2032)
  5. 5.2 Global Human Hepatitis B Immunoglobulin (HBIG) Sales by Type
  6. 5.2.1 Global Human Hepatitis B Immunoglobulin (HBIG) Sales by Type (2021 VS 2025 VS 2032)
  7. 5.2.2 Global Human Hepatitis B Immunoglobulin (HBIG) Sales by Type (2021-2032) & (K Units)
  8. 5.2.3 Global Human Hepatitis B Immunoglobulin (HBIG) Sales Market Share by Type (2021-2032)
  9. 5.3 Global Human Hepatitis B Immunoglobulin (HBIG) Price by Type
6 Human Hepatitis B Immunoglobulin (HBIG) Market by Application
  1. 6.1 Global Human Hepatitis B Immunoglobulin (HBIG) Revenue by Application
  2. 6.1.1 Global Human Hepatitis B Immunoglobulin (HBIG) Revenue by Application (2021 VS 2025 VS 2032)
  3. 6.1.2 Global Human Hepatitis B Immunoglobulin (HBIG) Revenue by Application (2021-2032) & (US$ Million)
  4. 6.1.3 Global Human Hepatitis B Immunoglobulin (HBIG) Revenue Market Share by Application (2021-2032)
  5. 6.2 Global Human Hepatitis B Immunoglobulin (HBIG) Sales by Application
  6. 6.2.1 Global Human Hepatitis B Immunoglobulin (HBIG) Sales by Application (2021 VS 2025 VS 2032)
  7. 6.2.2 Global Human Hepatitis B Immunoglobulin (HBIG) Sales by Application (2021-2032) & (K Units)
  8. 6.2.3 Global Human Hepatitis B Immunoglobulin (HBIG) Sales Market Share by Application (2021-2032)
  9. 6.3 Global Human Hepatitis B Immunoglobulin (HBIG) Price by Application
7 Company Profiles
  1. 7.1 Boya Bio-pharmaceutical
  2. 7.1.1 Boya Bio-pharmaceutical Company Information
  3. 7.1.2 Boya Bio-pharmaceutical Business Overview
  4. 7.1.3 Boya Bio-pharmaceutical Human Hepatitis B Immunoglobulin (HBIG) Sales, Revenue, Price and Gross Margin (2021-2026)
  5. 7.1.4 Boya Bio-pharmaceutical Human Hepatitis B Immunoglobulin (HBIG) Product Portfolio
  6. 7.1.5 Boya Bio-pharmaceutical Recent Developments
  7. 7.2 CSL
  8. 7.2.1 CSL Company Information
  9. 7.2.2 CSL Business Overview
  10. 7.2.3 CSL Human Hepatitis B Immunoglobulin (HBIG) Sales, Revenue, Price and Gross Margin (2021-2026)
  11. 7.2.4 CSL Human Hepatitis B Immunoglobulin (HBIG) Product Portfolio
  12. 7.2.5 CSL Recent Developments
  13. 7.3 Grifols
  14. 7.3.1 Grifols Company Information
  15. 7.3.2 Grifols Business Overview
  16. 7.3.3 Grifols Human Hepatitis B Immunoglobulin (HBIG) Sales, Revenue, Price and Gross Margin (2021-2026)
  17. 7.3.4 Grifols Human Hepatitis B Immunoglobulin (HBIG) Product Portfolio
  18. 7.3.5 Grifols Recent Developments
  19. 7.4 Octapharma
  20. 7.4.1 Octapharma Company Information
  21. 7.4.2 Octapharma Business Overview
  22. 7.4.3 Octapharma Human Hepatitis B Immunoglobulin (HBIG) Sales, Revenue, Price and Gross Margin (2021-2026)
  23. 7.4.4 Octapharma Human Hepatitis B Immunoglobulin (HBIG) Product Portfolio
  24. 7.4.5 Octapharma Recent Developments
  25. 7.5 Baxter
  26. 7.5.1 Baxter Company Information
  27. 7.5.2 Baxter Business Overview
  28. 7.5.3 Baxter Human Hepatitis B Immunoglobulin (HBIG) Sales, Revenue, Price and Gross Margin (2021-2026)
  29. 7.5.4 Baxter Human Hepatitis B Immunoglobulin (HBIG) Product Portfolio
  30. 7.5.5 Baxter Recent Developments
  31. 7.6 Bayer
  32. 7.6.1 Bayer Company Information
  33. 7.6.2 Bayer Business Overview
  34. 7.6.3 Bayer Human Hepatitis B Immunoglobulin (HBIG) Sales, Revenue, Price and Gross Margin (2021-2026)
  35. 7.6.4 Bayer Human Hepatitis B Immunoglobulin (HBIG) Product Portfolio
  36. 7.6.5 Bayer Recent Developments
  37. 7.7 Tiantan Biologic
  38. 7.7.1 Tiantan Biologic Company Information
  39. 7.7.2 Tiantan Biologic Business Overview
  40. 7.7.3 Tiantan Biologic Human Hepatitis B Immunoglobulin (HBIG) Sales, Revenue, Price and Gross Margin (2021-2026)
  41. 7.7.4 Tiantan Biologic Human Hepatitis B Immunoglobulin (HBIG) Product Portfolio
  42. 7.7.5 Tiantan Biologic Recent Developments
  43. 7.8 Shuanglin Bio-pharmacy
  44. 7.8.1 Shuanglin Bio-pharmacy Company Information
  45. 7.8.2 Shuanglin Bio-pharmacy Business Overview
  46. 7.8.3 Shuanglin Bio-pharmacy Human Hepatitis B Immunoglobulin (HBIG) Sales, Revenue, Price and Gross Margin (2021-2026)
  47. 7.8.4 Shuanglin Bio-pharmacy Human Hepatitis B Immunoglobulin (HBIG) Product Portfolio
  48. 7.8.5 Shuanglin Bio-pharmacy Recent Developments
  49. 7.9 Hualan Biological
  50. 7.9.1 Hualan Biological Company Information
  51. 7.9.2 Hualan Biological Business Overview
  52. 7.9.3 Hualan Biological Human Hepatitis B Immunoglobulin (HBIG) Sales, Revenue, Price and Gross Margin (2021-2026)
  53. 7.9.4 Hualan Biological Human Hepatitis B Immunoglobulin (HBIG) Product Portfolio
  54. 7.9.5 Hualan Biological Recent Developments
  55. 7.10 Shanghai RAAS
  56. 7.10.1 Shanghai RAAS Company Information
  57. 7.10.2 Shanghai RAAS Business Overview
  58. 7.10.3 Shanghai RAAS Human Hepatitis B Immunoglobulin (HBIG) Sales, Revenue, Price and Gross Margin (2021-2026)
  59. 7.10.4 Shanghai RAAS Human Hepatitis B Immunoglobulin (HBIG) Product Portfolio
  60. 7.10.5 Shanghai RAAS Recent Developments
  61. 7.11 Sichuan Yuanda Shuyang
  62. 7.11.1 Sichuan Yuanda Shuyang Company Information
  63. 7.11.2 Sichuan Yuanda Shuyang Business Overview
  64. 7.11.3 Sichuan Yuanda Shuyang Human Hepatitis B Immunoglobulin (HBIG) Sales, Revenue, Price and Gross Margin (2021-2026)
  65. 7.11.4 Sichuan Yuanda Shuyang Human Hepatitis B Immunoglobulin (HBIG) Product Portfolio
  66. 7.11.5 Sichuan Yuanda Shuyang Recent Developments
  67. 7.12 China Biologic
  68. 7.12.1 China Biologic Company Information
  69. 7.12.2 China Biologic Business Overview
  70. 7.12.3 China Biologic Human Hepatitis B Immunoglobulin (HBIG) Sales, Revenue, Price and Gross Margin (2021-2026)
  71. 7.12.4 China Biologic Human Hepatitis B Immunoglobulin (HBIG) Product Portfolio
  72. 7.12.5 China Biologic Recent Developments
  73. 7.13 Shanghai Institute of Biological
  74. 7.13.1 Shanghai Institute of Biological Company Information
  75. 7.13.2 Shanghai Institute of Biological Business Overview
  76. 7.13.3 Shanghai Institute of Biological Human Hepatitis B Immunoglobulin (HBIG) Sales, Revenue, Price and Gross Margin (2021-2026)
  77. 7.13.4 Shanghai Institute of Biological Human Hepatitis B Immunoglobulin (HBIG) Product Portfolio
  78. 7.13.5 Shanghai Institute of Biological Recent Developments
8 North America
  1. 8.1 North America Human Hepatitis B Immunoglobulin (HBIG) Market Size by Type
  2. 8.1.1 North America Human Hepatitis B Immunoglobulin (HBIG) Revenue by Type (2021-2032)
  3. 8.1.2 North America Human Hepatitis B Immunoglobulin (HBIG) Sales by Type (2021-2032)
  4. 8.1.3 North America Human Hepatitis B Immunoglobulin (HBIG) Price by Type (2021-2032)
  5. 8.2 North America Human Hepatitis B Immunoglobulin (HBIG) Market Size by Application
  6. 8.2.1 North America Human Hepatitis B Immunoglobulin (HBIG) Revenue by Application (2021-2032)
  7. 8.2.2 North America Human Hepatitis B Immunoglobulin (HBIG) Sales by Application (2021-2032)
  8. 8.2.3 North America Human Hepatitis B Immunoglobulin (HBIG) Price by Application (2021-2032)
  9. 8.3 North America Human Hepatitis B Immunoglobulin (HBIG) Market Size by Country
  10. 8.3.1 North America Human Hepatitis B Immunoglobulin (HBIG) Revenue Grow Rate by Country (2021 VS 2025 VS 2032)
  11. 8.3.2 North America Human Hepatitis B Immunoglobulin (HBIG) Sales by Country (2021 VS 2025 VS 2032)
  12. 8.3.3 North America Human Hepatitis B Immunoglobulin (HBIG) Price by Country (2021-2032)
  13. 8.3.4 United States
  14. 8.3.5 Canada
  15. 8.3.6 Mexico
9 Europe
  1. 9.1 Europe Human Hepatitis B Immunoglobulin (HBIG) Market Size by Type
  2. 9.1.1 Europe Human Hepatitis B Immunoglobulin (HBIG) Revenue by Type (2021-2032)
  3. 9.1.2 Europe Human Hepatitis B Immunoglobulin (HBIG) Sales by Type (2021-2032)
  4. 9.1.3 Europe Human Hepatitis B Immunoglobulin (HBIG) Price by Type (2021-2032)
  5. 9.2 Europe Human Hepatitis B Immunoglobulin (HBIG) Market Size by Application
  6. 9.2.1 Europe Human Hepatitis B Immunoglobulin (HBIG) Revenue by Application (2021-2032)
  7. 9.2.2 Europe Human Hepatitis B Immunoglobulin (HBIG) Sales by Application (2021-2032)
  8. 9.2.3 Europe Human Hepatitis B Immunoglobulin (HBIG) Price by Application (2021-2032)
  9. 9.3 Europe Human Hepatitis B Immunoglobulin (HBIG) Market Size by Country
  10. 9.3.1 Europe Human Hepatitis B Immunoglobulin (HBIG) Revenue Grow Rate by Country (2021 VS 2025 VS 2032)
  11. 9.3.2 Europe Human Hepatitis B Immunoglobulin (HBIG) Sales by Country (2021 VS 2025 VS 2032)
  12. 9.3.3 Europe Human Hepatitis B Immunoglobulin (HBIG) Price by Country (2021-2032)
  13. 9.3.4 Germany
  14. 9.3.5 France
  15. 9.3.6 U.K.
  16. 9.3.7 Italy
  17. 9.3.8 Russia
  18. 9.3.9 Spain
  19. 9.3.10 Netherlands
10 China
  1. 10.1 China Human Hepatitis B Immunoglobulin (HBIG) Market Size by Type
  2. 10.1.1 China Human Hepatitis B Immunoglobulin (HBIG) Revenue by Type (2021-2032)
  3. 10.1.2 China Human Hepatitis B Immunoglobulin (HBIG) Sales by Type (2021-2032)
  4. 10.1.3 China Human Hepatitis B Immunoglobulin (HBIG) Price by Type (2021-2032)
  5. 10.2 China Human Hepatitis B Immunoglobulin (HBIG) Market Size by Application
  6. 10.2.1 China Human Hepatitis B Immunoglobulin (HBIG) Revenue by Application (2021-2032)
  7. 10.2.2 China Human Hepatitis B Immunoglobulin (HBIG) Sales by Application (2021-2032)
  8. 10.2.3 China Human Hepatitis B Immunoglobulin (HBIG) Price by Application (2021-2032)
11 Asia (Excluding China)
  1. 11.1 Asia Human Hepatitis B Immunoglobulin (HBIG) Market Size by Type
  2. 11.1.1 Asia Human Hepatitis B Immunoglobulin (HBIG) Revenue by Type (2021-2032)
  3. 11.1.2 Asia Human Hepatitis B Immunoglobulin (HBIG) Sales by Type (2021-2032)
  4. 11.1.3 Asia Human Hepatitis B Immunoglobulin (HBIG) Price by Type (2021-2032)
  5. 11.2 Asia Human Hepatitis B Immunoglobulin (HBIG) Market Size by Application
  6. 11.2.1 Asia Human Hepatitis B Immunoglobulin (HBIG) Revenue by Application (2021-2032)
  7. 11.2.2 Asia Human Hepatitis B Immunoglobulin (HBIG) Sales by Application (2021-2032)
  8. 11.2.3 Asia Human Hepatitis B Immunoglobulin (HBIG) Price by Application (2021-2032)
  9. 11.3 Asia Human Hepatitis B Immunoglobulin (HBIG) Market Size by Country
  10. 11.3.1 Asia Human Hepatitis B Immunoglobulin (HBIG) Revenue Grow Rate by Country (2021 VS 2025 VS 2032)
  11. 11.3.2 Asia Human Hepatitis B Immunoglobulin (HBIG) Sales by Country (2021 VS 2025 VS 2032)
  12. 11.3.3 Asia Human Hepatitis B Immunoglobulin (HBIG) Price by Country (2021-2032)
  13. 11.3.4 Japan
  14. 11.3.5 South Korea
  15. 11.3.6 India
  16. 11.3.7 Australia
  17. 11.3.8 Taiwan
  18. 11.3.9 Southeast Asia
12 South America, Middle East and Africa
  1. 12.1 SAMEA Human Hepatitis B Immunoglobulin (HBIG) Market Size by Type
  2. 12.1.1 SAMEA Human Hepatitis B Immunoglobulin (HBIG) Revenue by Type (2021-2032)
  3. 12.1.2 SAMEA Human Hepatitis B Immunoglobulin (HBIG) Sales by Type (2021-2032)
  4. 12.1.3 SAMEA Human Hepatitis B Immunoglobulin (HBIG) Price by Type (2021-2032)
  5. 12.2 SAMEA Human Hepatitis B Immunoglobulin (HBIG) Market Size by Application
  6. 12.2.1 SAMEA Human Hepatitis B Immunoglobulin (HBIG) Revenue by Application (2021-2032)
  7. 12.2.2 SAMEA Human Hepatitis B Immunoglobulin (HBIG) Sales by Application (2021-2032)
  8. 12.2.3 SAMEA Human Hepatitis B Immunoglobulin (HBIG) Price by Application (2021-2032)
  9. 12.3 SAMEA Human Hepatitis B Immunoglobulin (HBIG) Market Size by Country
  10. 12.3.1 SAMEA Human Hepatitis B Immunoglobulin (HBIG) Revenue Grow Rate by Country (2021 VS 2025 VS 2032)
  11. 12.3.2 SAMEA Human Hepatitis B Immunoglobulin (HBIG) Sales by Country (2021 VS 2025 VS 2032)
  12. 12.3.3 SAMEA Human Hepatitis B Immunoglobulin (HBIG) Price by Country (2021-2032)
  13. 12.3.4 Brazil
  14. 12.3.5 Argentina
  15. 12.3.6 Chile
  16. 12.3.7 Colombia
  17. 12.3.8 Peru
  18. 12.3.9 Saudi Arabia
  19. 12.3.10 Israel
  20. 12.3.11 UAE
  21. 12.3.12 Turkey
  22. 12.3.13 Iran
  23. 12.3.14 Egypt
13 Value Chain and Sales Channels Analysis
  1. 13.1 Human Hepatitis B Immunoglobulin (HBIG) Value Chain Analysis
  2. 13.1.1 Human Hepatitis B Immunoglobulin (HBIG) Key Raw Materials
  3. 13.1.2 Raw Materials Key Suppliers
  4. 13.1.3 Manufacturing Cost Structure
  5. 13.1.4 Human Hepatitis B Immunoglobulin (HBIG) Production Mode & Process
  6. 13.2 Human Hepatitis B Immunoglobulin (HBIG) Sales Channels Analysis
  7. 13.2.1 Direct Comparison with Distribution Share
  8. 13.2.2 Human Hepatitis B Immunoglobulin (HBIG) Distributors
  9. 13.2.3 Human Hepatitis B Immunoglobulin (HBIG) Customers
14 Concluding Insights
    15 Appendix
    1. 15.1 Reasons for Doing This Study
    2. 15.2 Research Methodology
    3. 15.3 Research Process
    4. 15.4 Authors List of This Report
    5. 15.5 Data Source
    6. 15.5.1 Secondary Sources
    7. 15.5.2 Primary Sources
    8. 15.6 Disclaimer

    GET THE RESEARCH

    Choose your license.

    Choose who needs access.
    All options are for this report and research series.

    Compare access permissions.

    Single User License
    One named user. Individual access.
    Multi User License
    Up to 5 users in the same department.
    Enterprise License
    Organization-wide access within the agreed license.

    Access applies to the purchased edition. Later editions are separate purchases.

    License options
    $4,950USD
    Buy now

    PDF by email within 3–5 working days after payment confirmation.

    Talk to an analyst
    APO Research
    Talk to an analyst